During its most recent quarterly earnings, Johnson & Johnson announced plans to separate its Orthopedics business to enhance strategic and operational focus. The transaction would establish a ...
Phillip Kennedy Johnson has been known in comic books for Superman, Action Comics, Alien, Green Lantern: War Journal and Hellhunters for Marvel and DC, while co-creator of The Fellspyre Chronicles, ...
The identity of the comic's buyer has not been publicly released. It's a bird! It's a plane! No – it’s the most expensive comic ever sold! An original "Superman" No. 1 comic, printed by DC Comics in ...
This is read by an automated voice. Please report any issues or inconsistencies here. It’s a bird, it’s a plane ... it’s a Superman comic beyond most of our price range! A pristine copy of “Superman” ...
A comic found in an attic has become the most valuable ever after being sold for $9.12 million. The pristine copy of the first Superman comic was found by three brothers stored in their late mother’s ...
An original copy of the first edition of the first "Superman" comic from 1939 — which had been lying undiscovered in an attic for decades — was sold at auction on Thursday for more than $9 million, ...
Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...
Rahul Malhotra is a Weekend News Writer for Collider. From Francois Ozon to David Fincher, he'll watch anything once. He has been writing for Collider for over two years, and has covered everything ...
I last analyzed Johnson & Johnson (JNJ) stock on 8.14 with an article titled “Back To Basics: Why I Favor Amgen Over Johnson & Johnson”. It rated JNJ stock as HOLD after considering the issues caused ...
Despite being born into a family of A-listers, Dakota Johnson's foray into Hollywood wasn't as smooth as you might think. She "always wanted to be an actress and be a part of what the people around me ...
Shares of Johnson & Johnson were rising into record territory in early trading Tuesday, after the medicines and medical-technology giant beat quarterly earnings expectations and raised its outlook, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results